default author photo

Robert Kozak

University of Toronto - Department of Laboratory Medicine and Pathobiology

Medical Sciences Building, 6th Floor

1 King's College Circle

Toronto, Ontario M5S 1A8

Canada

SCHOLARLY PAPERS

2

DOWNLOADS

210

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Peginterferon-Lambda for the Treatment of COVID-19 in Outpatients

Number of pages: 41 Posted: 21 Jan 2021
Viral Hepatitis Care Network (VIRCAN), Faculty of Medicine, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, University of Toronto - Department of Laboratory Medicine and Pathobiology, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, University Health Network, University of Toronto, Division of Infectious Diseases, William Osler Health System, University Health Network, University of Toronto, Michael Garron Hospital, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, University of Toronto - Saint Michael's Hospital, Trillium Health Partners, University Health Network, University of Toronto, University of Toronto - Transplant Infectious Diseases and Multi-Organ Transplant Program, University of Toronto - Transplant Infectious Diseases and Multi-Organ Transplant Program, Sunnybrook Health Sciences Centre, University of Toronto, North York General Hospital, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, University of Toronto - Toronto Centre for Liver Disease, Sunnybrook Health Sciences Centre, University of Toronto, Sunnybrook Health Sciences Centre, University of Toronto, Eiger BioPharmaceuticals, Eiger BioPharmaceuticals, The Li Ka Shing Institute of Virology, University of Alberta, The Li Ka Shing Institute of Virology, University of Alberta, Departments of Medicine and Microbiology & Immunology, Stanford University School of Medicine, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto and Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, University of Toronto
Downloads 105 (664,543)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Type III Interferon, Antiviral Therapy, Viral Load, Outpatients

2.

Intensive Supportive Care Alone Does Not Impact Survival in a Lethal Non-Human Primate Model of Ebola Virus Disease

Number of pages: 24 Posted: 28 Aug 2018
Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Medtronic Canada, Public Health Agency of Canada, Public Health Agency of Canada, Canadian Food Inspection Agency, Public Health Agency of Canada - Special Pathogens Program, University of Saskatchewan, Université Laval, National Institutes of Health - Laboratory of Virology, University of Manitoba, Royal University Hospital, Public Health Agency of Canada, Providence Infectious Disease Clinic, Western University, Health Sciences Centre Winnipeg, University of Manitoba, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, St. Boniface Hospital Albrechtsen Research Centre, University of Manitoba, University of Manitoba, University of Manitoba, University of Manitoba, Winnipeg Regional Health Authority, Public Health Agency of Canada, University of Manitoba, Public Health Agency of Canada, University of ManitobaPublic Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, University of Toronto - Department of Laboratory Medicine and Pathobiology, Public Health Agency of Canada and Public Health Agency of Canada - National Microbiology Laboratory
Downloads 105 (669,616)

Abstract:

Loading...